The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2021. This month are seven guidelines and one technology appraisal that impact upon primary care.
The COVID-19 rapid guideline: managing COVID-19 guideline has been updated. It covers the management of COVID-19 for children, young people and adults in all care settings. The update references publication via a global evidence platform.
The Atrial fibrillation: diagnosis and management guideline has been updated. It covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding. The update recommends using the ORBIT score to assess bleeding risk.
The Autism spectrum disorder in under 19s: support and management guideline has been updated. It covers the different ways that health and social care professionals can provide support, treatment and help for children and young people with autism, and their families and carers, from the early years through to their transition into young adult life. This updates adds new recommendations on interventions for feeding problems, including restricted diets.
The Autism spectrum disorder in adults: diagnosis and management guideline has been updated. It covers diagnosing and managing suspected or confirmed autism spectrum disorder in people aged 18 and over. It aims to improve access and engagement with interventions and services, and the experience of care, for people with autism. The update clarifies that a person who scores 6 or above on the AQ-10 should be offered a comprehensive assessment.
The Shared decision making guideline has been published. It covers how to make shared decision making part of everyday care in all healthcare settings. It promotes ways for healthcare professionals and people using services to work together to make decisions about treatment and care. It includes recommendations on training, communicating risks, benefits and consequences, using decision aids, and how to embed shared decision making in organisational culture and practices.
The Patient experience in adult NHS services guideline has been updated. It covers the components of a good patient experience. It aims to make sure that all adults using NHS services have the best possible experience of care. The update replaces several recommendations on share decision making and refers to the newly published guideline mentioned above.
The Acne vulgaris: management guideline has been published. It covers the management of acne vulgaris in primary and specialist care. It includes advice on topical and oral treatments (including antibiotics and retinoids), treatment using physical modalities, and the impact of acne vulgaris on mental health and wellbeing.
The Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis technology appraisal has been published. This treatment is recommended as an option for inducing remission of eosinophilic oesophagitis in adults. It is noted that since the appraisal process began the product license has been extended to include maintenance treatment but as no evidence was submitted for this newly licensed indication no recommendation is made at this time for maintenance.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.